1	Induction	Induction	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	activator	activator	_	_	_	_	_	_	_
4	protein	protein	_	_	_	_	_	_	_
5	(	(	_	_	_	_	_	_	_
6	AP)-1	ap)-1	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	nuclear	nuclear	_	_	_	_	_	_	_
9	factor-kappaB	factor-kappab	_	_	_	_	_	_	_
10	by	by	_	_	_	_	_	_	_
11	CD28	cd28	_	_	_	_	_	_	_
12	stimulation	stimulation	_	_	_	_	_	_	_
13	involves	involve	_	_	_	_	_	_	_
14	both	both	_	_	_	_	_	_	_
15	phosphatidylinositol	phosphatidylinositol	_	_	_	_	_	_	_
16	3-kinase	3-kinase	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	acidic	acidic	_	_	_	_	_	_	_
19	sphingomyelinase	sphingomyelinase	_	_	_	_	_	_	_
20	signals	signal	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	A	a	_	_	_	_	_	_	_
2	major	major	_	_	_	_	_	_	_
3	obstacle	obstacle	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	understanding	understand	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	signaling	signaling	_	_	_	_	_	_	_
8	events	event	_	_	_	_	_	_	_
9	that	that	_	_	_	_	_	_	_
10	follow	follow	_	_	_	_	_	_	_
11	CD28	cd28	_	_	_	_	_	_	_
12	receptor	receptor	_	_	_	_	_	_	_
13	ligation	ligation	_	_	_	_	_	_	_
14	arises	arise	_	_	_	_	_	_	_
15	from	from	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	fact	fact	_	_	_	_	_	_	_
18	that	that	_	_	_	_	_	_	_
19	CD28	cd28	_	_	_	_	_	_	_
20	acts	act	_	_	_	_	_	_	_
21	as	as	_	_	_	_	_	_	_
22	a	a	_	_	_	_	_	_	_
23	costimulus	costimulus	_	_	_	_	_	_	_
24	to	to	_	_	_	_	_	_	_
25	TCR	TCR	_	_	_	_	_	_	_
26	engagement	engagement	_	_	_	_	_	_	_
27	,	,	_	_	_	_	_	_	_
28	making	make	_	_	_	_	_	_	_
29	it	it	_	_	_	_	_	_	_
30	difficult	difficult	_	_	_	_	_	_	_
31	to	to	_	_	_	_	_	_	_
32	assess	assess	_	_	_	_	_	_	_
33	the	the	_	_	_	_	_	_	_
34	relative	relative	_	_	_	_	_	_	_
35	contribution	contribution	_	_	_	_	_	_	_
36	of	of	_	_	_	_	_	_	_
37	CD28	cd28	_	_	_	_	_	_	_
38	signals	signal	_	_	_	_	_	_	_
39	as	as	_	_	_	_	_	_	_
40	distinct	distinct	_	_	_	_	_	_	_
41	from	from	_	_	_	_	_	_	_
42	those	those	_	_	_	_	_	_	_
43	of	of	_	_	_	_	_	_	_
44	the	the	_	_	_	_	_	_	_
45	TCR	TCR	_	_	_	_	_	_	_
46	.	.	_	_	_	_	_	_	_

1	To	to	_	_	_	_	_	_	_
2	overcome	overcome	_	_	_	_	_	_	_
3	this	this	_	_	_	_	_	_	_
4	problem	problem	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	we	we	_	_	_	_	_	_	_
7	have	have	_	_	_	_	_	_	_
8	exploited	exploit	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	observation	observation	_	_	_	_	_	_	_
11	that	that	_	_	_	_	_	_	_
12	activated	activate	_	_	_	_	_	_	_
13	human	human	_	_	_	_	_	_	_
14	T	t	_	_	_	_	_	_	_
15	cell	cell	_	_	_	_	_	_	_
16	blasts	blast	_	_	_	_	_	_	_
17	can	can	_	_	_	_	_	_	_
18	be	be	_	_	_	_	_	_	_
19	stimulated	stimulate	_	_	_	_	_	_	_
20	via	via	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	CD28	cd28	_	_	_	_	_	_	_
23	surface	surface	_	_	_	_	_	_	_
24	molecule	molecule	_	_	_	_	_	_	_
25	in	in	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	absence	absence	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	antigenic	antigenic	_	_	_	_	_	_	_
30	challenge	challenge	_	_	_	_	_	_	_
31	;	;	_	_	_	_	_	_	_
32	thus	thus	_	_	_	_	_	_	_
33	,	,	_	_	_	_	_	_	_
34	we	we	_	_	_	_	_	_	_
35	have	have	_	_	_	_	_	_	_
36	been	be	_	_	_	_	_	_	_
37	able	able	_	_	_	_	_	_	_
38	to	to	_	_	_	_	_	_	_
39	observe	observe	_	_	_	_	_	_	_
40	the	the	_	_	_	_	_	_	_
41	response	response	_	_	_	_	_	_	_
42	of	of	_	_	_	_	_	_	_
43	normal	normal	_	_	_	_	_	_	_
44	T	t	_	_	_	_	_	_	_
45	cells	cell	_	_	_	_	_	_	_
46	to	to	_	_	_	_	_	_	_
47	CD28	cd28	_	_	_	_	_	_	_
48	activation	activation	_	_	_	_	_	_	_
49	in	in	_	_	_	_	_	_	_
50	isolation	isolation	_	_	_	_	_	_	_
51	.	.	_	_	_	_	_	_	_

1	Using	use	_	_	_	_	_	_	_
2	this	this	_	_	_	_	_	_	_
3	system	system	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	we	we	_	_	_	_	_	_	_
6	observed	observe	_	_	_	_	_	_	_
7	that	that	_	_	_	_	_	_	_
8	CD28	cd28	_	_	_	_	_	_	_
9	stimulation	stimulation	_	_	_	_	_	_	_
10	by	by	_	_	_	_	_	_	_
11	B7-transfected	b7-transfected	_	_	_	_	_	_	_
12	CHO	CHO	_	_	_	_	_	_	_
13	cells	cell	_	_	_	_	_	_	_
14	induced	induce	_	_	_	_	_	_	_
15	a	a	_	_	_	_	_	_	_
16	proliferative	proliferative	_	_	_	_	_	_	_
17	response	response	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	T	t	_	_	_	_	_	_	_
20	cells	cell	_	_	_	_	_	_	_
21	that	that	_	_	_	_	_	_	_
22	was	be	_	_	_	_	_	_	_
23	not	not	_	_	_	_	_	_	_
24	accompanied	accompany	_	_	_	_	_	_	_
25	by	by	_	_	_	_	_	_	_
26	measurable	measurable	_	_	_	_	_	_	_
27	IL-2	il-2	_	_	_	_	_	_	_
28	production	production	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	subsequent	subsequent	_	_	_	_	_	_	_
4	analysis	analysis	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	transcription	transcription	_	_	_	_	_	_	_
7	factor	factor	_	_	_	_	_	_	_
8	generation	generation	_	_	_	_	_	_	_
9	revealed	reveal	_	_	_	_	_	_	_
10	that	that	_	_	_	_	_	_	_
11	B7	b7	_	_	_	_	_	_	_
12	stimulation	stimulation	_	_	_	_	_	_	_
13	induced	induce	_	_	_	_	_	_	_
14	both	both	_	_	_	_	_	_	_
15	activator	activator	_	_	_	_	_	_	_
16	protein-1	protein-1	_	_	_	_	_	_	_
17	(	(	_	_	_	_	_	_	_
18	AP-1	ap-1	_	_	_	_	_	_	_
19	)	)	_	_	_	_	_	_	_
20	and	and	_	_	_	_	_	_	_
21	nuclear	nuclear	_	_	_	_	_	_	_
22	factor-kappaB	factor-kappab	_	_	_	_	_	_	_
23	(	(	_	_	_	_	_	_	_
24	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
25	)	)	_	_	_	_	_	_	_
26	complexes	complex	_	_	_	_	_	_	_
27	,	,	_	_	_	_	_	_	_
28	but	but	_	_	_	_	_	_	_
29	not	not	_	_	_	_	_	_	_
30	NF-AT	NF-AT	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	engagement	engagement	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	TCR	TCR	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	class	class	_	_	_	_	_	_	_
10	II	ii	_	_	_	_	_	_	_
11	MHC/superantigen	mhc/superantigen	_	_	_	_	_	_	_
12	,	,	_	_	_	_	_	_	_
13	either	either	_	_	_	_	_	_	_
14	with	with	_	_	_	_	_	_	_
15	or	or	_	_	_	_	_	_	_
16	without	without	_	_	_	_	_	_	_
17	CD28	cd28	_	_	_	_	_	_	_
18	ligation	ligation	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	resulted	result	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	induction	induction	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	NF-AT	NF-AT	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	AP-1	ap-1	_	_	_	_	_	_	_
28	,	,	_	_	_	_	_	_	_
29	and	and	_	_	_	_	_	_	_
30	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
31	as	as	_	_	_	_	_	_	_
32	well	well	_	_	_	_	_	_	_
33	as	as	_	_	_	_	_	_	_
34	IL-2	il-2	_	_	_	_	_	_	_
35	production	production	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

1	Using	use	_	_	_	_	_	_	_
2	selective	selective	_	_	_	_	_	_	_
3	inhibitors	inhibitor	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	we	we	_	_	_	_	_	_	_
6	investigated	investigate	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	signaling	signaling	_	_	_	_	_	_	_
9	pathways	pathway	_	_	_	_	_	_	_
10	involved	involve	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	CD28-mediated	cd28-mediated	_	_	_	_	_	_	_
14	induction	induction	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	AP-1	AP-1	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	revealed	reveal	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
5	generation	generation	_	_	_	_	_	_	_
6	was	be	_	_	_	_	_	_	_
7	sensitive	sensitive	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	chloroquine	chloroquine	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	an	an	_	_	_	_	_	_	_
12	inhibitor	inhibitor	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	acidic	acidic	_	_	_	_	_	_	_
15	sphingomyelinase	sphingomyelinase	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	but	but	_	_	_	_	_	_	_
18	not	not	_	_	_	_	_	_	_
19	to	to	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	phosphatidylinositol	phosphatidylinositol	_	_	_	_	_	_	_
22	3-kinase	3-kinase	_	_	_	_	_	_	_
23	inhibitor	inhibitor	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	wortmannin	wortmannin	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	AP-1	ap-1	_	_	_	_	_	_	_
5	generation	generation	_	_	_	_	_	_	_
6	was	be	_	_	_	_	_	_	_
7	inhibited	inhibit	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	wortmannin	wortmannin	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	was	be	_	_	_	_	_	_	_
12	also	also	_	_	_	_	_	_	_
13	variably	variably	_	_	_	_	_	_	_
14	sensitive	sensitive	_	_	_	_	_	_	_
15	to	to	_	_	_	_	_	_	_
16	chloroquine	chloroquine	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	data	datum	_	_	_	_	_	_	_
3	suggest	suggest	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	activated	activate	_	_	_	_	_	_	_
7	normal	normal	_	_	_	_	_	_	_
8	T	t	_	_	_	_	_	_	_
9	cells	cell	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	CD28-derived	cd28-derived	_	_	_	_	_	_	_
12	signals	signal	_	_	_	_	_	_	_
13	can	can	_	_	_	_	_	_	_
14	stimulate	stimulate	_	_	_	_	_	_	_
15	proliferation	proliferation	_	_	_	_	_	_	_
16	at	at	_	_	_	_	_	_	_
17	least	least	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	part	part	_	_	_	_	_	_	_
20	via	via	_	_	_	_	_	_	_
21	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	AP-1	ap-1	_	_	_	_	_	_	_
24	generation	generation	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	and	and	_	_	_	_	_	_	_
27	that	that	_	_	_	_	_	_	_
28	this	this	_	_	_	_	_	_	_
29	response	response	_	_	_	_	_	_	_
30	uses	use	_	_	_	_	_	_	_
31	both	both	_	_	_	_	_	_	_
32	acidic	acidic	_	_	_	_	_	_	_
33	sphingomyelinase	sphingomyelinase	_	_	_	_	_	_	_
34	and	and	_	_	_	_	_	_	_
35	phosphatidylinositol	phosphatidylinositol	_	_	_	_	_	_	_
36	3-kinase-linked	3-kinase-linked	_	_	_	_	_	_	_
37	pathways	pathway	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

